| Adapted treatment guided by interim PET-CT scan in advanced Hodgkin’s lymphoma P Johnson, M Federico, A Kirkwood, A Fosså, L Berkahn, A Carella, ... New England Journal of Medicine 374 (25), 2419-2429, 2016 | 807 | 2016 |
| International, evidence-based consensus diagnostic criteria for HHV-8–negative/idiopathic multicentric Castleman disease DC Fajgenbaum, TS Uldrick, A Bagg, D Frank, D Wu, G Srkalovic, ... Blood, The Journal of the American Society of Hematology 129 (12), 1646-1657, 2017 | 496 | 2017 |
| Siltuximab for multicentric Castleman's disease: a randomised, double-blind, placebo-controlled trial F Van Rhee, RS Wong, N Munshi, JF Rossi, XY Ke, A Fosså, D Simpson, ... The lancet oncology 15 (9), 966-974, 2014 | 455 | 2014 |
| International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease F Van Rhee, P Voorhees, A Dispenzieri, A Fosså, G Srkalovic, M Ide, ... Blood, The Journal of the American Society of Hematology 132 (20), 2115-2124, 2018 | 316 | 2018 |
| Procarbazine-free OEPA-COPDAC chemotherapy in boys and standard OPPA-COPP in girls have comparable effectiveness in pediatric Hodgkin’s lymphoma: the GPOH-HD-2002 study C Mauz-Körholz, D Hasenclever, W Dörffel, K Ruschke, T Pelz, A Voigt, ... J Clin Oncol 28 (23), 3680-3686, 2010 | 293 | 2010 |
| Peroxisomal multifunctional beta-oxidation protein of Saccharomyces cerevisiae. Molecular analysis of the fox2 gene and gene product. JK Hiltunen, B Wenzel, A Beyer, R Erdmann, A Fosså, WH Kunau Journal of Biological Chemistry 267 (10), 6646-6653, 1992 | 247 | 1992 |
| First-line treatment and outcome of elderly patients with primary central nervous system lymphoma (PCNSL)—a systematic review and individual patient data meta-analysis B Kasenda, AJM Ferreri, E Marturano, D Forst, J Bromberg, ... Annals of Oncology 26 (7), 1305-1313, 2015 | 187 | 2015 |
| Metabolic profiling indicates impaired pyruvate dehydrogenase function in myalgic encephalopathy/chronic fatigue syndrome Ø Fluge, O Mella, O Bruland, K Risa, SE Dyrstad, K Alme, IG Rekeland, ... JCI insight 1 (21), 2016 | 186 | 2016 |
| PET-CT for staging and early response: results from the Response-Adapted Therapy in Advanced Hodgkin Lymphoma study SF Barrington, AA Kirkwood, A Franceschetto, MJ Fulham, TH Roberts, ... Blood, The Journal of the American Society of Hematology 127 (12), 1531-1538, 2016 | 186 | 2016 |
| qPET–a quantitative extension of the Deauville scale to assess response in interim FDG-PET scans in lymphoma D Hasenclever, L Kurch, C Mauz-Körholz, A Elsner, T Georgi, H Wallace, ... European journal of nuclear medicine and molecular imaging 41, 1301-1308, 2014 | 151 | 2014 |
| Left ventricular function assessed by two-dimensional speckle tracking echocardiography in long-term survivors of Hodgkin's lymphoma treated by mediastinal radiotherapy with or … HR Tsai, O Gjesdal, T Wethal, KH Haugaa, A Fosså, SD Fosså, ... The American journal of cardiology 107 (3), 472-477, 2011 | 148 | 2011 |
| Valvular dysfunction and left ventricular changes in Hodgkin's lymphoma survivors. A longitudinal study T Wethal, MB Lund, T Edvardsen, SD Fosså, AH Pripp, H Holte, ... British journal of cancer 101 (4), 575-581, 2009 | 142 | 2009 |
| Dose-densified chemoimmunotherapy followed by systemic central nervous system prophylaxis for younger high-risk diffuse large B-cell/follicular grade 3 lymphoma patients … H Holte, S Leppä, M Björkholm, Ø Fluge, S Jyrkkiö, J Delabie, ... Annals of oncology 24 (5), 1385-1392, 2013 | 126 | 2013 |
| Pneumocystis jirovecii pneumonia in B-cell lymphoma patients treated with the rituximab-CHOEP-14 regimen A Kolstad, H Holte, A Fosså, GF Lauritzsen, P Gaustad, D Torfoss Haematologica 92 (1), 139-140, 2007 | 107 | 2007 |
| Serological cloning of cancer/testis antigens expressed in prostate cancer using cDNA phage surface display A Fosså, L Alsøe, R Crameri, S Funderud, G Gaudernack, EB Smeland Cancer Immunology, Immunotherapy 53, 431-438, 2004 | 105 | 2004 |
| Successful change of treatment strategy in elderly patients with primary central nervous system lymphoma by de-escalating induction and introducing temozolomide maintenance … EJ Pulczynski, O Kuittinen, M Erlanson, H Hagberg, A Fosså, M Eriksson, ... haematologica 100 (4), 534, 2015 | 95 | 2015 |
| NY‐ESO‐1 protein expression and humoral immune responses in prostate cancer A Fosså, A Berner, SD Fosså, E Hernes, G Gaudernack, EB Smeland The Prostate 59 (4), 440-447, 2004 | 95 | 2004 |
| Whole-transcriptome sequencing identifies novel IRF2BP2-CDX1 fusion gene brought about by translocation t (1; 5)(q42; q32) in mesenchymal chondrosarcoma KB Nyquist, I Panagopoulos, J Thorsen, L Haugom, L Gorunova, ... PloS one 7 (11), e49705, 2012 | 93 | 2012 |
| Post-treatment parenthood in Hodgkin's lymphoma survivors CE Kiserud, A Fosså, H Holte, SD Fosså British journal of cancer 96 (9), 1442-1449, 2007 | 81 | 2007 |
| Gonadal function in male patients after treatment for malignant lymphomas, with emphasis on chemotherapy CE Kiserud, A Fosså, T Bjøro, H Holte, M Cvancarova, SD Fosså British journal of cancer 100 (3), 455-463, 2009 | 76 | 2009 |
